Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function

Cancer Research

Volumn 68, Issue 19, 2008, Pages 7718-7722

  Liao, Yi Chun ^a   Shih, Yi Ping ^a   Su, Hao Lo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DLC 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; FOCAL ADHESION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LIVER CANCER; PRIORITY JOURNAL; TUMOR GROWTH;

CELLS, CULTURED; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MUTATION; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEINS;

EID: 54249145175     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2042     Document Type: Article

References (20)

1. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998;58:2196-99.
2. Liao YC, Lo SH. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol 2008;40:843-7.
3. Durkin ME, Yuan BZ, Zhou X, et al. DLC-1:a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med 2007;11:1185-207.
4. Qiao F, Bowie JU. The many faces of SAM. Sci STKE 2005;286:re7.
5. Iyer LM, Aravind L, Koonin EV. Common origin of four diverse families of large eukaryotic DNA viruses. J Virol 2001;75:11720-34.
6. Sekimata M, Kabuyama Y, Emori Y, Homma Y. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J Biol Chem 1999;274:17757-62.
7. Wong CM, Yam JW, Ching YP, et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 2005;65:8861-8.
8. Yam JW, Ko FC, Chan CY, Jin DY, Ng IO. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res 2006;66:8367-72.
9. Homma Y, Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-δ stimulating activities. EMBO J 1995;14:286-91.
10. Yamaga M, Sekimata M, Fujii M, et al. A PLCδ1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells 2004;9:25-37.
11. Liao YC, Si L, Devere White RW, Lo SH. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol 2007;176:43-9.
12. Qian X, Li G, Asmussen HK, et al. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A 2007;104:9012-7.
13. Kawai K, Yamaga M, Iwamae Y, et al. A PLCδ1-binding protein, p122RhoGAP, is localized in focal adhesions. Biochem Soc Trans 2004;32:1107-9.
14. Pang JC, Chang Q, Chung YF, et al. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol 2005;36:36-43.
15. Hewitt C, Wilson P, McGlinn E, et al. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma. Cancer Lett 2004;209:207-13.
16. Zheng SL, Mychaleckyj JC, Hawkins GA, et al. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. Mutat Res 2003;528:45-53.
17. Wilson PJ, McGlinn E, Marsh A, et al. Sequence variants of DLC1 in colorectal and ovarian tumours. Hum Mutat 2000;15:156-65.
18. Ullmannova V, Popescu NC. Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol 2006;29:1127-32.
19. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007;129:865-77.
20. Hers I, Wherlock M, Homma Y, Yagisawa H, Tavare JM. Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells. J Biol Chem 2006;281:4762-70.